RESUMO
BACKGROUND: Despite the established benefit of intramuscular (i.m.) influenza vaccination, new adjuvants and delivery methods for comparable or improved immunogenicity are being explored. Intradermal (i.d.) antigen administration is hypothesized to initiate an efficient immune response at reduced antigen doses similar to that observed after i.m. full dose vaccination. METHODS: In a randomized, partially blinded phase II study 224, healthy adults aged >or=18 to Assuntos
Vacinas contra Influenza/imunologia
, Vacinas Virossomais/imunologia
, Administração Cutânea
, Adolescente
, Adulto
, Feminino
, Humanos
, Vacinas contra Influenza/administração & dosagem
, Vacinas contra Influenza/efeitos adversos
, Masculino
, Pessoa de Meia-Idade
, Segurança
, Vacinação
, Vacinas Virossomais/administração & dosagem
, Vacinas Virossomais/efeitos adversos